{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:13:16Z","timestamp":1790017996017,"version":"4.0.1"},"reference-count":11,"publisher":"Universa BV","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGEB"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>In this case report, we describe two cases of gastric mucosa-\nassociated lymphoid tissue (MALT) lymphoma. The first patient,\nwho presented with complaints of indigestion, nausea and\nepigastralgy, had a solid ulcer on endoscopy. Biopsies showed,\nnext to MALT, presence of Helicobacter Pylori. The second\npatient was admitted with hematemesis. The multiple ulcerations\nin his stomach were thought to be cocaine-induced. Only after\nmultiple biopsies the diagnosis of MALT was made. No presence\nof Helicobacter Pylori could be detected. The first patient was\nsuccessfully treated with Helicobacter Pylori eradication therapy.\nLocalized radiotherapy resulted in complete remission in our\nsecond patient. Hence, in absence of Helicobacter Pylori, more\naggressive treatment modalities are needed.<\/jats:p>","DOI":"10.51821\/84.4.016","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T15:20:40Z","timestamp":1637767240000},"page":"653-655","source":"Crossref","is-referenced-by-count":3,"title":["Gastric MALT-Lymphoma: more than Helicobacter Pylori"],"prefix":"10.51821","volume":"84","author":[{"given":"G","family":"Van de Vyver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Vandamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H.","family":"Steger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Staessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27062","published-online":{"date-parts":[[2021,11]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"CAPELLE, L.G., et al., Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer, 2008. 44(16): 2470-6.","DOI":"10.1016\/j.ejca.2008.07.005"},{"key":"ref1","unstructured":"ZULLO, A., et al., Gastric MALT lymphoma: old and new insights. Ann Gastroenterol, 2014. 27(1): 27-33."},{"key":"ref2","unstructured":"DIACONU, S., et al., Helicobacter pylori infection: old and new. J Med Life, 2017. 10(2): 112-117."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"ZUCCA, E., et al., Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2020. 31(1): 17-29.","DOI":"10.1016\/j.annonc.2019.10.010"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"VIOLETA Filip, P., et al., MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life, 2018. 11(3): 187-193.","DOI":"10.25122\/jml-2018-0035"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"CHESON, B.D., et al., Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol, 2014. 32(27): 3059-68.","DOI":"10.1200\/jco.2013.54.8800"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"OLSZEWSKA-SZOPA, M., T. WROBEL. Gastrointestinal non-Hodgkin lymphomas. Adv Clin Exp Med, 2019. 28(8): 1119-1124.","DOI":"10.17219\/acem\/94068"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"ASENJO, L.M., J.P. GISBERT. [Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review]. Rev Esp Enferm Dig, 2007. 99(7): 398-404.","DOI":"10.4321\/s1130-01082007000700006"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"ASANO, N., et al., Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review. World J Gastroenterol, 2015. 21(26): 8014-20.","DOI":"10.3748\/wjg.v21.i26.8014"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"ABE, S., et al., A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy. Jpn J Clin Oncol, 2013. 43(9): 917-22.","DOI":"10.1093\/jjco\/hyt097"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"ZULLO, A., et al., Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review. J Clin Gastroenterol, 2013. 47(10): 824-7.","DOI":"10.1097\/mcg.0b013e318286ff72"}],"container-title":["Acta Gastro Enterologica Belgica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T15:43:00Z","timestamp":1644853380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ageb.be\/ageb-journal\/ageb-volume\/ageb-article\/1964\/Gastric%20MALT-Lymphoma:%20more%20than%20Helicobacter%20Pylori\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,10]]},"published-print":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.51821\/84.4.016","relation":{},"ISSN":["1784-3227"],"issn-type":[{"value":"1784-3227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}